When something goes wrong with an AI assistant, our instinct is to ask it directly: "What happened?" or "Why did you do that?

10 stocks we like better than Recursion Pharmaceuticals › Before market open on Tuesday, Recursion Pharmaceuticals (NASDAQ: RXRX) published its latest set of quarterly earnings and business update.

But Why is a show led by kids. They ask the questions and we find the answers. It’s a big interesting world out there. On But Why, we tackle topics large and small, about nature, words, even the ...